PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1514835
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1514835
Global Enteral Syringe Market is valued at approximately USD 383.6 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2024-2032. Enteral syringes are specialized medical devices used to administer liquid medications, nutrients, or fluids directly into the gastrointestinal tract through a feeding tube. These syringes feature accurate volume measurements, compatibility with enteral feeding tubes, and safety mechanisms to prevent accidental disconnection or leakage. Enteral syringes are essential in enteral nutrition, particularly for patients unable to swallow or consume food orally due to conditions like dysphagia, neurological disorders, gastrointestinal disorders, or recovery from surgery. The increasing incidence of malnutrition serves as a significant driver for market growth.
The global rise in malnutrition cases, driven by factors such as poverty, inadequate access to nutritious food, chronic illnesses, and aging populations, underscores the critical role of enteral syringes in delivering essential nutrients. This rising need for efficient nutrition management propels the demand for enteral syringes. However, stringent governmental regulations impose challenges on market growth. Compliance with strict standards and approval processes requires significant investments, leading to prolonged product approval timelines and increased manufacturing costs, which can hinder market expansion. Despite these challenges, the development of advanced feeding devices with reduced side effects presents lucrative opportunities. Innovations in enteral syringe design, materials, and functionalities, aimed at enhancing patient comfort and treatment outcomes, are expected to drive market growth during the forecast period.
The key regions considered for the global enteral syringe market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the enteral syringe market in terms of revenue. The market growth in the region is being attributed to factors including well-established healthcare infrastructure, high prevalence of chronic diseases, and favorable reimbursement policies. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by rapid improvements in healthcare infrastructure, increased awareness about enteral nutrition therapy, and rising healthcare investments.